ISL
BLUE

Ingalls & Snyder LLC’s bluebird bio BLUE Stock Holding History

Ingalls & Snyder LLC’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-617
Closed -$431K – 427
2020
Q3 		$431K Sell
617
-77
-11% -$60.1K 0.03% 259
2020
Q2 		$549K Buy
694
+1
+0.1% +$754 0.03% 246
2020
Q1 		$412K Sell
693
-62
-8% -$60.4K 0.03% 277
2019
Q4 		$859K Sell
755
-375
-33% -$408K 0.05% 212
2019
Q3 		$1.34M Sell
1,130
-15
-1% -$22.9K 0.07% 187
2019
Q2 		$1.89M Buy
+1,145
New +$1.98M 0.09% 159

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ingalls & Snyder LLC's BLUE Position: Q4 2020 in Review

Ingalls & Snyder LLC sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 617 shares — an estimated $431K sold.

Ingalls & Snyder LLC first reported a position in BLUE in Q2 2019 and held it in 6 quarters. The position peaked at $1.89M in Q2 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Ingalls & Snyder LLC reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 617 bluebird bio shares in Q4 2020, an estimated $431K.
  • Ingalls & Snyder LLC first reported a position in bluebird bio in Q2 2019 and held it in 6 quarters.
  • Ingalls & Snyder LLC's bluebird bio position peaked at $1.89M in Q2 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2020, filed 27 Jan 2021.